Lupus update: perspective and clinical pearls.
Patients with systemic lupus erythematosus (SLE, lupus) have a markedly better survival rate today than they did 50 years ago, but they face a greater risk of cancer, cardiovascular disease, and osteoporosis at early ages. With better understanding of the immunological mechanisms of the disease, new avenues of therapy are emerging.
Manzi
Susan
S
Director, Patient Care and Translational Research, Lupus Center of Excellence, University of Pittsburgh School of Medicine and Graduate School of Public Health, Pittsburgh, PA 15261, USA. sxm6+@pitt.edu
D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000628:therapy*; D008297:Male